The European Medicines Agency (EMA) has published a final report on the experience gained during its pilot project to involve patients directly in the assessment of the benefits and risks of medicines in its Committee for Medicinal Products for Human Use (CHMP). (...)
US data blurs the picture for bond investors
-
The combination of slower growth and nagging inflation is an unsettling mix
4 ore fa
Post
Nessun commento:
Posta un commento